OCUL stock forecast
Our latest prediction for Ocular Therapeutix, Inc.'s stock price was made on the Jan. 2, 2020 when the stock price was at 3.95$.
In the short term (2weeks), OCUL's stock price should outperform the market by 0.27%. During that period the price should oscillate between -10.44% and +14.16%.
In the medium term (3months), OCUL's stock price should underperform the market by -12.01%. During that period the price should oscillate between -45.73% and +34.60%.Get email alerts
About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -1.79$ per share.
The book value per share is 1.18$
Three months stock forecastJan. 2, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|